Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Assessment of Quadrivalent Subunit Influenza Vaccine in China
NCT07710586Phase 4Completed
- Sponsor
- Ab&B Bio-tech Co., Ltd.
- Start
- Nov 2024
- Primary completion
- May 2025
- Countries
- 1
01
Overview
A Phase 4 trial of quadrivalent influenza virus subunit vaccine (Ab&B Bio-tech) in influenza, sponsored by Ab&B Bio-tech Co., Ltd.. Started Nov 2024; status: completed.
02
Drugs
quadrivalent influenza virus subunit vaccine (Ab&B Bio-tech)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07710586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07710586.